
The company will actively engage with the agency and take all necessary steps required to address the United States Food and Drug Administration (USFDA) concerns, Panacea Biotec said.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2S8RNLz
via
IFTTT
0 comments:
Post a Comment